CINTHIA URIARTE: Open Payments
NPI 1114752615 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 2 | $57 |
| United Therapeutics Corporation | 2 | $46 |
| Verona Pharma, Inc. | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: Prolastin-C Liquid, Ohtuvayre, OPSUMIT, DATROWAY, YUPELRI, RYBREVANT, Tyvaso, Cresemba.
Industry payments across AZ — which companies pay providers there.
